A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/09/2006	US20060252686 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
11/09/2006	US20060252679 Preventive and/or trerapeutic drgs for itch
11/09/2006	US20060252674 Methods for pretreating a subject with extracorporeal photopheresis
11/09/2006	US20060252673 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole
11/09/2006	US20060252670 Method of reducing drug-induced adverse side effects in a patient
11/09/2006	US20060252154 Assay to identify estrogen receptor dependent ligands that regulate the hepatic lipase promoter
11/09/2006	US20060252113 Methods for identifying compounds that modulate an enzyme in the glucose metabolic pathway of a pathogenic microorganism
11/09/2006	US20060252112 Methods for indentifying compounds that modulate an enzyme involved in biotin metabolism in a pathogenic microorganism
11/09/2006	US20060252104 Screening for a compound to inhibit the urge for urinary incontinence by detecting activation of KCNQ protein in the host cell; measuring the membrane potential of the host cell and selecting the compound whose presence causes hyperpolarization in themembrane potential of the host cell
11/09/2006	US20060252102 Assays for c-mannosyltransferases
11/09/2006	US20060252045 Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
11/09/2006	US20060252037 Expression vector comprising antisense nuclelotide sequence which decrease exxpression from kinase suppressor of RAS (KRAS) for use in the treatment and prevention of cell proliferative disorders
11/09/2006	US20060252036 Alteration of rab38 function to modulate mammalian pigmentation
11/09/2006	US20060252035 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
11/09/2006	US20060251753 Ellagic acid food supplement prepared from pomegranate seed
11/09/2006	US20060251751 Sophoridine and its use as an analgesic
11/09/2006	US20060251750 Soy formulations and their use in skin care
11/09/2006	US20060251749 Compositions Of Bakuchiol And Methods Of Making The Same
11/09/2006	US20060251742 CO2 extraction techniques provide reduced levels of methysticin and dihydromethysticin with increased levels of kavain and dihydrokavain; paste, powder, liquid, or rapid-dissolve tablet; enhances efficacy of a botanical extract co-ingredient
11/09/2006	US20060251740 Witherferin A derivatives and analogs extracted from Withania somnifera; preferential COX-2 inhibitors with little or no COX-1 activity; anticarcinogenic agents
11/09/2006	US20060251739 Composition and method for treating autoimmune disease and mucosal disorder
11/09/2006	US20060251738 Rock flour, especially dolomite-based medicament, for the treatment of cancer diseases
11/09/2006	US20060251736 Complementary compositions to reduce blood glucose levels and treat diabetes
11/09/2006	US20060251735 Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
11/09/2006	US20060251734 enhancing cancer cell death using therapeutically effective amounts of DNA damaging agent(s) that act in combination to enhance cancer cell death, e.g., nucleic acid precursors, and protein tyrosine kinase inhibitors, e.g., that inhibit EGFR activity; pancreatic cancer treatment
11/09/2006	US20060251733 Contacting cell with a composition comprising extracellular-signal-regulated kinase (ERK) activating agent in combination with a phosphatase inhibitor; treating inflammation
11/09/2006	US20060251727 Supplemental dietary composition for increasing muscle size, strength, athletic performance and/or exercise capacity
11/09/2006	US20060251725 Aggregation of particle sizes
11/09/2006	US20060251723 Formulations of a SRC/ABL inhibitor
11/09/2006	US20060251721 Hydrocodone and acetaminophen; twice-a-day administration; pain relievers
11/09/2006	US20060251720 Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins
11/09/2006	US20060251718 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
11/09/2006	US20060251717 Controlling dosage; mixture of memantine hydrochloride with cellulose
11/09/2006	US20060251716 Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
11/09/2006	US20060251715 Oral delivery of a botanical
11/09/2006	US20060251714 Pharmaceutical formulations of amyloid inhibiting compounds
11/09/2006	US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier
11/09/2006	US20060251712 Method and composition for hyperthermally treating cells
11/09/2006	US20060251711 Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating diseases of the respiratory tract of a mammal
11/09/2006	US20060251710 Micelle composition of polymer and passenger drug
11/09/2006	US20060251708 Coenzyme q10 containing proliposome and preparation thereof
11/09/2006	US20060251705 Delivery of tigecycline in the presence of heparin
11/09/2006	US20060251703 Composition comprising an edible acid or its acidic salt and the use thereof
11/09/2006	US20060251702 Implantable materials and methods for inhibiting tissue adhesion formation
11/09/2006	US20060251690 Skin enrichment using CoQ10 as the delivery system
11/09/2006	US20060251689 Treatment or prevention of pruritus
11/09/2006	US20060251684 Decrease infectivity, morbidity, and/or mortality associated with pathogenic exposure while minimizing microbial resistance, toxicity to the recipient
11/09/2006	US20060251675 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
11/09/2006	US20060251663 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tisssue permeability
11/09/2006	US20060251661 Tumor lesion regression and conversion in situ into autologous tumor vaccines by compositions that result in anti-Gal Antibody Binding
11/09/2006	US20060251657 Treatment kit which assists with antibiotic therapy for intracellular infectious diseases
11/09/2006	US20060251656 New pharmaceutical compositions based on anticholinergics and anti-tnf antibodies
11/09/2006	US20060251654 Method for treatment of malignant and infectious chronic diseases
11/09/2006	US20060251653 Methods for treating interleukin-6 related diseases
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	US20060251649 Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
11/09/2006	US20060251648 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement
11/09/2006	US20060251646 Anti-tirc7 antibodies in therapy of inflammatiory diseases
11/09/2006	US20060251638 Cytoprotection through the use of hif hydroxylase inhibitors
11/09/2006	US20060251637 Oil-in-water type emulsion containing coenzyme q10 and process for producting the same
11/09/2006	US20060251634 Method of improving immune function in mammals using lactobacillus strains with certain lipids
11/09/2006	US20060251631 Treatment of joint disease, methods and apparatuses therefor
11/09/2006	US20060251617 Methods for treating lymphomas
11/09/2006	US20060251614 Aliphatic amine polymer salts for tableting
11/09/2006	US20060251612 Bioresorbable cyanoacrylate adhesives
11/09/2006	US20060251611 Antibacterial processing of fiber products
11/09/2006	US20060251610 Structure for separation of physiologically active agent and method for recovering physiologically active agent
11/09/2006	US20060251608 A Method of Treatment of Aging and Wrinkled Skin and a Kit Containing Compositions for Same
11/09/2006	US20060251592 Isoflavone derivatives
11/09/2006	US20060251590 Oral cereal beta glucan compositions
11/09/2006	US20060251589 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
11/09/2006	US20060251588 Delivery of erectile dysfunction drugs through an inhalation route
11/09/2006	US20060251587 Delivery of analgesics through an inhalation route
11/09/2006	US20060251586 Method for the Administration of an Anticholinergic by Inhalation
11/09/2006	US20060251579 Medicament for the two-step perioperative therapy of solid tumours
11/09/2006	US20060251578 Therapeutic and diagnostic compounds, compositions, and methods
11/09/2006	DE102005020882A1 Use of gaboxadol and its derivatives as kinase inhibitor for the treatment of e.g. kinase induced disease, cancer, age-related macular degeneration, diabetic retinopathy and angiogenesis
11/09/2006	DE102005020707A1 Cosmetic or pharmaceutical preparation, useful for skin care and for cleaning skin, contains hydrocarbons produced by gas liquefaction process
11/09/2006	DE102005019712A1 Dipyridyl-dihydropyrazolone und ihre Verwendung Dipyridyl dihydropyrazolones and their use
11/09/2006	DE102005019628A1 Formulierung zur dermalen Anwendung Formulation for dermal application
11/09/2006	DE102005014142B4 Pelletförmige Retardzubereitung gegen Schwindel Delayed-release pellet shaped against scams
11/09/2006	CA2831752A1 Non-lithotripsic kidney-stone therapy
11/09/2006	CA2613169A1 Use of carotenoids and/or carotenoid derivatives/analogs for reduction/inhibition of certain negative effects of cox inhibitors
11/09/2006	CA2611738A1 Systems and methods for treating human inflammatory and proliferative diseases, with a combination of compounds, or a bifunctional compound,that provides fatty acid metabolism andglycolysis inhibition
11/09/2006	CA2610296A1 Inhibition of reactive oxygen species and protection of mammalian cells
11/09/2006	CA2608283A1 Pharmaceutical compositions with synchronized solubilizer release
11/09/2006	CA2607780A1 Purine derivatives
11/09/2006	CA2607777A1 Transdermal absorption enhancer
11/09/2006	CA2607727A1 Cyanopyridine derivative and use thereof as medicine
11/09/2006	CA2607556A1 C-linked glucoronide of n-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth
11/09/2006	CA2607524A1 Agent for prophylaxis and treating of pancreatitis
11/09/2006	CA2607506A1 Novel lactam compound
11/09/2006	CA2607419A1 Granular preparation containing biguanide compound
11/09/2006	CA2607341A1 Diagnosis and treatment of endometriosis
11/09/2006	CA2607227A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/09/2006	CA2607185A1 Intracellular active agents
11/09/2006	CA2607183A1 Phosphoinositide modulation for the treatment of alzheimer's disease
11/09/2006	CA2607106A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/09/2006	CA2607101A1 Inhalation device containing plural doses of a pharmaceutical composition
11/09/2006	CA2607095A1 Compositions and methods for modulating dopamine neurotransmission

1 ... 4015 4016 4017 4018 4019 4020 4021 4022 4023 4024 4025 4026 4027 4028 4029 4030 4031 4032 4033 4034 4035 ... 7860